Form 4: Konstantinov Acquires Repligen Stock Units

Konstantin Konstantinov, a Director at Repligen Corp, was awarded 995 restricted stock units on May 14, 2026.

Summary

• Konstantin Konstantinov, a Director at Repligen Corporation, received an award of 995 restricted stock units (RSUs) on May 14, 2026.
• Each RSU represents a contingent right to receive one share of Repligen Corporation's Common Stock.
• These RSUs vest on the earlier of May 14, 2027 (one year from the grant date), or the date of the company's next annual shareholder meeting.
• The RSUs will be settled by delivering shares of Repligen Corporation's Common Stock.
• Following this transaction, Konstantinov beneficially owns 3,889 shares of common stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a standard compensation award to a director rather than a significant financial event or strategic shift.

Positives

• Director awarded restricted stock units, indicating a form of compensation and potential alignment with shareholder interests.
• The award of 995 RSUs suggests continued investment in key personnel.
• The securities are directly owned by the reporting person.

Risks

• Vesting is contingent on future events, including the date of the next annual shareholder meeting, which is not yet determined.
• The value of the award is tied to the future performance of Repligen Corporation's stock.

Future Outlook

The restricted stock units vest on the earlier of May 14, 2027, or the date of the next annual meeting of the Company's shareholders. The settlement of these units is dependent on the company's stock performance.

Industry Context

StockSavvy.ai notes that the issuance of restricted stock units to directors is a common practice in the biotechnology and life sciences sector to incentivize long-term performance and align executive interests with shareholders.

Stakeholder Impact

• Shareholders: The award of RSUs to a director can be viewed positively as it aligns management's interests with long-term shareholder value. However, the dilutive effect of future share issuance should be considered.
• Employees: This filing does not directly impact employees, but it reflects the company's compensation strategy for its leadership.
• Management: The award serves as a form of compensation and incentive for the director.

Next Steps

• Vesting of restricted stock units on May 14, 2027, or the date of the next annual shareholder meeting.
• Settlement of RSUs by delivering shares of Repligen Corporation's Common Stock upon vesting.

Key Dates

Keywords

Repligen Corp, RGEN, Form 4, Restricted Stock Units, RSU, Director Compensation, Insider Transaction, Beneficial Ownership